| Name | N'-(3-hydroxy-10,13-dimethyl-3,4,7,8,9,11,12,13,15,16-decahydro-1H-cyclopenta[a]phenanthren-17(2H,10H,14H)-ylidene)-4-methylbenzenesulfonohydrazide |
|---|---|
| Synonyms |
5alpha-Spirost-9(11)-en-3beta-ol,(25R)
5-dehydroepiandrosterone p-toluenesulfonyl hydrazone |
| Density | 1.33g/cm3 |
|---|---|
| Boiling Point | 606.4ºC at 760mmHg |
| Molecular Formula | C26H36N2O3S |
| Molecular Weight | 456.64100 |
| Flash Point | 320.5ºC |
| Exact Mass | 456.24500 |
| PSA | 87.14000 |
| LogP | 6.42470 |
|
~97%
34988-34-6 |
| Literature: CRYSTAL PHARMA, S.A.U.; Perez Encabo, Alfonso; Turiel Hernandez, Jose Angel; Gallo Nieto, Francisco Javier; Lorente Bonde-Larsen, Antonio; Sandoval Rodriguez, Celso Miguel Patent: US2014/11992 A1, 2014 ; Location in patent: Paragraph 0201; 0202; 0203 ; |
| Precursor 2 | |
|---|---|
| DownStream 1 | |